Skip to main content
Year archive

Keeps Biopharma Inc. — 2023 filings

All 25 regulatory filings released by Keeps Biopharma Inc. (256940) in 2023, sourced directly from the official regulator.

25 Filings
2023 Period
2023 filings (25)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-13 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-11-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-13 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-26 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-11 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
[기재정정]주주총회소집공고
AGM Information
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-03-13 Korean
주주총회소집결의
AGM Information
2023-03-13 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-03-09 Korean
단기차입금증가결정
Capital/Financing Update
2023-02-27 Korean
기타경영사항(자율공시)(제5회차 무기명식 무보증 사모 전환사채 취득 후 재매각의 건)
Capital/Financing Update
2023-02-27 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity
2023-02-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-01-03 Korean